CLINICAL_TRIALS
trial_result
· 2014-03-12
Clinical Trial Update: Pazopanib in Second-line Therapy in Renal Cell Carcinoma [Phase 2]
Summary
A Phase 2 trial update evaluating pazopanib as second-line therapy for metastatic renal cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Associació per a la Recerca Oncologica, Spain | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN